|
The NYU Medical Center Noninvasive Vascular Laboratory offers a wide range
of diagnostic as well as therapeutic options for the treatment of vascular
disease. Staffed by highly trained and experienced vascular technicians and
physicians, the laboratory is accredited by the Intersocietal Commission
for the Accreditation of Vascular Laboratories (ICAVL). Accreditation status
by ICAVL signifies that the facility has been reviewed by an independent
agency, which recognizes the laboratory’s commitment of quality testing
for diagnosis of vascular disease. Participation in the accreditation process
is voluntary and demonstrates the laboratory’s concern for high quality
patient care and attention to quality assurance.
The tests performed in the vascular laboratory are non-invasive and
painless. Blood pressure cuffs and soft ultrasound probes placed on the
skin are used for the tests, from which critical information is quickly
derived to assess circulatory problems. Arterial dopplers, venous duplex
ultrasound, and carotid artery duplex ultrasound are some of the procedures
performed in the laboratory for both inpatients and outpatients. These
tests allow physicians to assess arterial circulation in the legs, identify
dangerous narrowings in the neck arteries (carotid arteries) which can
lead to stroke, and test for potentially life threatening blood clots
in veins. These same vein blood clots may be the cause of troublesome
leg swelling and pain.
Treatment of certain aneurysms (ballooning of arteries) is also performed
in the vascular laboratory by physicians injecting clotting factors directly
under ultrasound guidance. Furthermore, the ultrasound vascular imaging
has been used in the operating rooms by vascular surgeons to identify
varicose veins which can then be obliterated using minimally invasive
technology such as radio-frequency ablation.
One American dies very 32 seconds of cardiovascular disease, disorders
of the heart and blood vessels. It is the leading cause of death in the
United States, costing society over 83 billion dollars each year in health
services, medications and lost work time due to disability. Stroke, a
disorder of the blood vessels to the brain, is the third leading cause
of death and disability in this country, with 500,000 new strokes occurring
annually.
Each year, 2 million people in the United States alone develop deep
vein thrombosis — blood clots in the veins. This becomes life-threatening
for 500,000 of those people when the blood clot breaks loose and travels
to their lungs. With early detection through the use of noninvasive vascular
testing, this disease can be prevented.
Although life-threatening if undetected, early detection of these vascular
diseases is possible through the use of noninvasive testing
techniques performed within the vascular laboratory.
|